Bridger Management’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q3
Sell
-142,979
Closed -$12.4M 33
2023
Q2
$12.4M Hold
142,979
4.11% 12
2023
Q1
$13.9M Buy
142,979
+540
+0.4% +$52.5K 5.17% 8
2022
Q4
$14.7M Buy
142,439
+42,039
+42% +$4.35M 5.96% 7
2022
Q3
$8.51M Sell
100,400
-107,400
-52% -$9.1M 2.58% 16
2022
Q2
$17.2M Buy
+207,800
New +$17.2M 3.88% 10